The best-ranked markers that allowed separation between t(15;17) AML blasts and those from t(8;21) AML group were HLA-DR, CD34, SSC, FSC, followed by CD13, CD33, and CD71 (Figure 5). Here, TFRC is linked to acute myeloid leukemia.